InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Dale Stephen, Directeur Médical. Insider active across 1 company, notably Kura Oncology, Inc.. Cumulatively, 4 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €128k. History available since 26 January 2022. The latest transaction was filed on 29 January 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Dale Stephen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
4,400 shares@ US$17.800556.4% of flowCommon StockSEC:0000950170-24-009493:0
23,125 shares0Common StockSEC:0001209191-23-011283:0
4,385 shares@ US$13.890343.6% of flowCommon StockSEC:0001209191-23-005744:0
36,900 shares0Common StockSEC:0001209191-22-005367:0
4 of 4 declarations
About Dale Stephen
Stephen Dale is the Chief Medical Officer at Kura Oncology, Inc. He oversees the company's medical and clinical initiatives, contributing to innovation and the development of new treatments. His role is essential for the company's success.
